Juan Capurro Boltendahl - Managing Director

Juan has over 20 years Investment Banking experience. He specializes in M&A transactions, Private Equity investments and Venture Capital projects. Prior to founding the M&A boutique Boltendahl in 1996, he worked with Deutsche Bank in Frankfurt, with the ING Group in Montevideo and with Banco Medefín in Buenos Aires. To date Juan is based in Madrid leading Boltendahl’s European operations. He is an advisor of several international companies in its acquisition and divestment strategies. His sector expertise focuses on: pharmaceuticals and healthcare, retail and consumer goods and TMT. He has led more than 25 M&A cases, advising a broad range of companies and funds.

His corporate finance expertise started back in the 80’s while holding and representing major shareholders in Germany’s biggest brandy company. Juan played an important role in the sale process to the Guinness/United Distillers Group. Juan is member of the IESE Alumni Association of Madrid and a founding member of the IESE Junta Territorial (IESE Regional Board) in Argentina and Uruguay. Other memberships include the Argentine-German chamber of commerce (CADICAA) and the Buenos Aires based FUAC – Foreign Universities Alumni Club. He is board member of several family controlled companies. Juan obtained his MBA at IESE in Barcelona and also attended Columbia University of New York. He speaks Spanish, English, German, Portuguese and French.

Contacto: capurro@boltendahl.com

^top

Erik Robert Hartmann - Director / Buenos Aires

Erik is member of the Board of the following companies: Tecnofarma SA of Argentina, Laboratorios Raffo of Chile and from investment company Perutil SA, formerly listed at the Swiss Stock Exchange. In 1984 Erik joined J.P. Morgan where he worked in the Zurich and New York offices, in both commercial banking and investment banking management positions.

Since 1990 Erik R. Hartmann works in the pharmaceutical industry, he is responsible for licensing and business development in Tecnofarma, a major Latin American pharmaceutical company.

Erik Hartmann has negotiated important corporate partnerships with multinational pharmaceutical and biotechnology companies such as Novartis, Switzerland; Purdue Pharma, USA; Biogenidec, USA; and LG Chemical, Korea. He originated and advised in a major acquisition by Novartis (Sandoz) in Argentina.

Erik was born in 1957, obtained his Master of Economics at the University of St. Gallen in Switzerland, is married and has two children. He has the Swiss and Argentine nationalities and speaks German, English and Spanish.

Contacto: hartmann@boltendahl.com

^top

Karl-Hermann Bremeyer - Director / Germany

Karl-Hermann has more than 30 years of pharmaceutical industry experience. In the last 15 years he was heavily involved in the biotechnology industry.

He played a key role in developing and implementing successful European market strategies for multiple products and indications. His responsibilities during this tenure included roles as Head of Chiron Biopharma Europe/International, Head of Marketing and Sales for Chiron Vaccines worldwide and Vice President of Chiron Therapeutics Europe.

Karl-Hermann is a well-known business developer with strong, proven track record and specialises in transfering academic findings into marketing products. He speaks German and English.

Contacto: bremeyer@boltendahl.com

^top

Bettina Karsch - Director

Bettina started working in Boltendahl in 1997, having previously worked in the Dresdner Bank in Frankfurt and Roche Laboratories in Montevideo. She specialises in human resources,  strategy, business plans and market research.

She obtained her Masters in International Business in the Ecole Nationale des Ponts et Chaussées, France and graduated from Brown University, USA with Magna Cum Laude. She speaks and writes fluently in English, German, French, and Spanish.

Contacto: karsch@boltendahl.com

^top

Marc Kitten - Non-Executive Director / Londres

Marc is an expert in finance and strategy consulting with over 14 years experience. From 2000 to 2003 he worked as a senior consultant in the London office of McKinsey & Company, serving financial institutions mainly in Europe. Prior to that, he spent 9 years at Deutsche Bank in Germany, France and Belgium, working as vice-president in its global markets division.

He is currently a member of the well-known Candesic consultancy, which is also associated with Boltendahl. He specialises in strategy, market analysis and market due diligence. In addition to his finance and consulting activities, Marc lectures in several European MBA programmes, including Edhec Theseus, Sciences Po and ESCP-EAP.

Marc obtained his MBA from the University of Chicago GSB. He also graduated from the Edhec business school and attended the Young Managers Program at INSEAD. He speaks French, English, German, and conversational Spanish and Russian.

Contacto: mkitten@boltendahl.com

^top

Jorge García Soto - Analyst

Jorge worked for 5 years in different pharmaceutical companies, such as Pfizer, Eli Lilly and Laboratorios Rovi. His experience relates to the therapeutic fields of Urology, Phitotherapy, Cardiology and New Products.

A Marketing graduate, he obtained a Masters in Management of Pharmaceutical companies. He speaks Spanish, English and conversational Italian.

Contacto: garcia-soto@boltendahl.com

^top

Mª Carmen Hidalgo - Office Management

Mª Carmen, with more than 10 years experience in different companies, is  assistant to the general Manager and in charge of the administration department.  One of her principal roles is the edition and translation of documents.

She studied Proffesional Secretary and successfully passed the Cambridge University ESOL examination Certificate of Proficiency in English. She speaks and writes fluently in Spanish and English.

Contacto: hidalgo@boltendahl.com

^top